Chen, Dalei
Otsuka (United States) · Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
5 papers on CoChatORCID 0009-0004-4264-7248
Most cited papers
- Verified
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Lassen, M. R., Raskob, G. E., Gallus, A., Pineo, G., Chen, D., & Hornick, P. (2010) · The Lancet
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 777
- Verified
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
Lassen, M. R., Gallus, A., Raskob, G. E., Pineo, G., Chen, D., & Ramirez, L. M. (2010) · New England Journal of Medicine
Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms
Cited by 775
- Verified · note
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
Lee, D., Slomkowski, M., Hefting, N., Chen, D., Larsen, K. G., Kohegyi, E., Hobart, M., Cummings, J. L., & Grossberg, G. T. (2023) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 135
- Verified
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Mathews, M., Gommoll, C., Chen, D., Nunez, R., & Khan, A. (2015) · International Clinical Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 77
- Verified
Efficacy, safety and tolerability of brexpiprazole for the treatment of agitation in Alzheimer's dementia: a 12-week, randomized, double-blind, placebo-controlled trial
Grossberg, G., Lee, D., Slomkowski, M., Hefting, N., Chen, D., Larsen, K. G., Kohegyi, E., Hobart, M., & Cummings, J. (2023) · The American Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free